Clinical Trials Logo

Clinical Trial Summary

Primary Objective: Explore the efficacy of teicoplanin (100-200 mg administered orally twice a day for 7 to 14 days) in patients with Clostridium difficile infection-associated diarrhea and colitis Secondary Objective: Evaluate the safety of teicoplanin in patients with Clostridium difficile infection-associated diarrhea and colitis


Clinical Trial Description

Approximate 10 weeks ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04003818
Study type Interventional
Source Sanofi
Contact
Status Terminated
Phase Phase 4
Start date May 15, 2020
Completion date March 10, 2021